These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 14630854)

  • 21. Viral pneumonia as a serious complication of etanercept therapy.
    Smith D; Letendre S
    Ann Intern Med; 2002 Jan; 136(2):174. PubMed ID: 11790076
    [No Abstract]   [Full Text] [Related]  

  • 22. Etanercept-induced subacute cutaneous lupus erythematosus.
    Bleumink GS; ter Borg EJ; Ramselaar CG; Stricker BH
    Rheumatology (Oxford); 2001 Nov; 40(11):1317-9. PubMed ID: 11709621
    [No Abstract]   [Full Text] [Related]  

  • 23. Cellulitis caused by Capnocytophaga cynodegmi associated with etanercept treatment in a patient with rheumatoid arthritis.
    Gerster JC; Dudler J
    Clin Rheumatol; 2004 Dec; 23(6):570-1. PubMed ID: 15278747
    [No Abstract]   [Full Text] [Related]  

  • 24. [Therapy of rheumatoid arthritis with etanercept].
    Lamprecht P; Nitschmann S
    Internist (Berl); 2009 May; 50(5):633-4. PubMed ID: 19350212
    [No Abstract]   [Full Text] [Related]  

  • 25. Antineutrophil cytoplasmic antibody-associated necrotizing crescentic glomerulonephritis in a patient receiving treatment with etanercept for severe rheumatoid arthritis.
    Doulton TW; Tucker B; Reardon J; Velasco N
    Clin Nephrol; 2004 Sep; 62(3):234-8. PubMed ID: 15481857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Safety and Efficacy of Etanercept in Rheumatoid Arthritis With End-stage Chronic Renal Failure].
    Mahmoud I; Gafsi L; Tekaya R; Saidane O; Sahli H; Abdelmoula L; Zouari R
    Therapie; 2015; 70(3):311-2. PubMed ID: 25997838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Etanercept related pseudo-empyema in rheumatoid arthritis.
    Rimar D; Rozenbaum M; Slobodin G; Boulman N; Rosner I
    Clin Rheumatol; 2010 May; 29(5):547-9. PubMed ID: 20127398
    [No Abstract]   [Full Text] [Related]  

  • 28. Diffuse skin reaction after changing the etanercept formulation.
    Caporali R; Bobbio-Pallavicini F; Caprioli M; Scorletti E; Montecucco C
    Clin Exp Rheumatol; 2008; 26(6):1165. PubMed ID: 19210894
    [No Abstract]   [Full Text] [Related]  

  • 29. Staphylococcus aureus sepsis after etanercept induction in a hemodialysis patient.
    Ikumi N; Matsukawa Y; Kuwana Y; Kodaira H; Tanaka T; Maruyama N; Nozawa S; Horikoshi A; Takeuchi J
    Hemodial Int; 2013 Jan; 17(1):133-5. PubMed ID: 22742581
    [No Abstract]   [Full Text] [Related]  

  • 30. Etanercept-induced dermatitis in a patient with rheumatoid arthritis.
    Lai-Cheong J; Warren R; Bucknall R; Parslew R
    J Eur Acad Dermatol Venereol; 2006 May; 20(5):614-5. PubMed ID: 16684300
    [No Abstract]   [Full Text] [Related]  

  • 31. Etanercept-induced Wegener granulomatosis in a patient with rheumatoid arthritis.
    Broshtilova V; Iliev E; Gantcheva M
    Dermatol Ther; 2013; 26(1):73-6. PubMed ID: 23384023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe pancytopenia following etanercept administration in rheumatoid arthritis.
    Martínez Santana V; Izquierdo Navarro M; Calleja Hernández MÁ; Sánchez Sánchez T; Sainz Gil M
    Int J Rheum Dis; 2012 Aug; 15(4):e78-9. PubMed ID: 22898233
    [No Abstract]   [Full Text] [Related]  

  • 33. Etanercept-induced necrotizing crescentic glomerulonephritis in two patients with rheumatoid arthritis.
    Kaneko K; Nanki T; Hosoya T; Mizoguchi F; Miyasaka N
    Mod Rheumatol; 2010 Dec; 20(6):632-6. PubMed ID: 20617355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful treatment with very low-dose etanercept in a patient with etanercept-induced liver dysfunction.
    Iwamoto M; Minota S
    Rheumatol Int; 2011 Apr; 31(4):561-2. PubMed ID: 20349067
    [No Abstract]   [Full Text] [Related]  

  • 35. New onset systemic lupus erythematosus in a patient receiving etanercept for rheumatoid arthritis.
    Cairns AP; Duncan MK; Hinder AE; Taggart AJ
    Ann Rheum Dis; 2002 Nov; 61(11):1031-2. PubMed ID: 12379532
    [No Abstract]   [Full Text] [Related]  

  • 36. Etanercept induced organizing pneumonia in a patient with rheumatoid arthritis.
    Cho SK; Oh IH; Park CK; Bae SC; Sung YK
    Rheumatol Int; 2012 Apr; 32(4):1055-7. PubMed ID: 20062996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-TNF agents for rheumatoid arthritis.
    Seymour HE; Worsley A; Smith JM; Thomas SH
    Br J Clin Pharmacol; 2001 Mar; 51(3):201-8. PubMed ID: 11298065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Henoch-Schönlein purpura in a patient with rheumatoid arthritis receiving etanercept.
    Asahina A; Ohshima N; Nakayama H; Shirai A; Juji T; Matsui T
    Eur J Dermatol; 2010; 20(4):521-2. PubMed ID: 20413370
    [No Abstract]   [Full Text] [Related]  

  • 39. Ophthalmic manifestations of demyelination secondary to etanercept.
    Do HH; Mohamed A; Klistorner A; Grigg J
    Clin Exp Ophthalmol; 2008 May; 36(4):392-4. PubMed ID: 18700932
    [No Abstract]   [Full Text] [Related]  

  • 40. Pulmonary rheumatoid nodules in an etanercept-treated patient.
    Hübscher O; Re R; Iotti R
    Arthritis Rheum; 2003 Jul; 48(7):2077-8. PubMed ID: 12847707
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.